taxonomy (1)
protein (5)
source (4)
structure (4)
composition (1)
disease (2)
reference (4)
site (5)
peptide (3)
- Homo sapiens (Human)
Taxonomy
- Immunoglobulin heavy constant alpha 1 / Homo sapiens P01876
- P-selectin glycoprotein ligand (psgl-1) / Homo sapiens Q14242
- Plasma protease c1 inhibitor / Homo sapiens P05155
- Prostaglandin-h2 d-isomerase / Homo sapiens P41222
- Uncharacterized protein / Homo sapiens
Protein
- Milk (UBERON_0001913)
- Urine (UBERON_0001088)
- HL-60 (CVCL_0002) Leukocyte (CL_0000738)
- Granulocyte (CL_0000094)
Source
- O-Linked / Core 2 / Fuc(a1-2)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)[Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-6)]Gal(b1-4)GlcNAc(b1-6)[NeuAc(a2-3)Gal(b1-3)]GalNAc
- O-Linked / Core 2 / Fuc(a1-2)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)[Gal(b1-4)GlcNAc(b1-6)]Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-6)[NeuAc(a2-3)Gal(b1-3)]GalNAc
- O-Linked / Core 2 / Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-6)[NeuAc(a2-3)Gal(b1-3)]GalNAc
- O-Linked / Core 2 / NeuAc(a2-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-6)[Gal(b1-3)]GalNAc
Reported structure
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Structures of the O-glycans on P-selectin glycoprotein ligand-1 from HL-60 cells. (1996 - Wilkins P, McEver R, Cummings R) / Status : Reviewed
- Primary structure of twenty three neutral and monosialylated oligosaccharides O-glycosidically linked to the human secretory immunoglobulin A hinge region determined by a combination of permethylation analysis and 400-MHz 1H-NMR spectroscopy. (1989 - Pierce-Cretel A, Decottignies J, Wieruszeski J, Strecker G, Montreuil J, Spik G) / Status : Reviewed
- Structures of O-linked oligosaccharides isolated from normal granulocytes, chronic myelogenous leukemia cells, and acute myelogenous leukemia cells. (1986 - Fukuda M, Carlsson S, Klock J, Dell A) / Status : Reviewed
Reference
-
Immunoglobulin heavy constant alpha 1 / Homo sapiens
- Undefined site
-
P-selectin glycoprotein ligand (psgl-1) / Homo sapiens
- Undefined site
- Plasma protease c1 inhibitor / Homo sapiens
- Prostaglandin-h2 d-isomerase / Homo sapiens
-
Uncharacterized protein / Homo sapiens
- Undefined site
Reported glycosite
- ASSNPNATSSSSQDPESLQDRGEGK (25aa)
- ASSNPNATSSSSQDPESLQDR (21aa)
- SVVAPATDGGLNLTSTFLR (19aa)
Mass spectrometry observed peptide
-
- O-Linked / Core 2
(avg mass : 2209.0518)
- Milk (UBERON_0001913)
-
Immunoglobulin heavy constant alpha 1 / Homo sapiens
- Undefined site
-
- O-Linked / Core 2
(avg mass : 2209.0518)
- Milk (UBERON_0001913)
-
Immunoglobulin heavy constant alpha 1 / Homo sapiens
- Undefined site
-
- O-Linked / Core 2
(avg mass : 2209.0518)
- Granulocyte (CL_0000094)
-
Uncharacterized protein / Homo sapiens
- Undefined site
-
- O-Linked / Core 2
(avg mass : 2209.0518)
- HL-60 (CVCL_0002) Leukocyte (CL_0000738)
-
P-selectin glycoprotein ligand (psgl-1) / Homo sapiens
- Undefined site
-
- Hex:4 HexNAc:4 dHex:3 NeuAc:1 / O-Linked
(avg mass : 2209.0518)
- Urine (UBERON_0001088)
- O-Linked / Core 2 / Fuc(a1-2)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)[Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-6)]Gal(b1-4)GlcNAc(b1-6)[NeuAc(a2-3)Gal(b1-3)]GalNAc
- O-Linked / Core 2 / Fuc(a1-2)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)[Gal(b1-4)GlcNAc(b1-6)]Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-6)[NeuAc(a2-3)Gal(b1-3)]GalNAc
- O-Linked / Core 2 / Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-6)[NeuAc(a2-3)Gal(b1-3)]GalNAc
- O-Linked / Core 2 / NeuAc(a2-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-6)[Gal(b1-3)]GalNAc
- Prostate cancer (DOID:10283)
- Plasma protease c1 inhibitor / Homo sapiens
- Prostaglandin-h2 d-isomerase / Homo sapiens
- ASSNPNATSSSSQDPESLQDRGEGK (25aa)
- ASSNPNATSSSSQDPESLQDR (21aa)
- SVVAPATDGGLNLTSTFLR (19aa)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:4 HexNAc:4 dHex:3 NeuAc:1 / O-Linked
(avg mass : 2209.0518)
Source
Reported glycosite
- O-Linked / Core 2
(avg mass : 2209.0518)
Source
Reported glycosite
- O-Linked / Core 2
(avg mass : 2209.0518)
Source
Reported glycosite
- O-Linked / Core 2
(avg mass : 2209.0518)
Source
Reported glycosite
- O-Linked / Core 2
(avg mass : 2209.0518)